Can a cardiac dysrhythmia cause vertigo, and what is the appropriate evaluation and treatment?

Vertigo Caused by Cardiac Dysrhythmia

Yes, cardiac dysrhythmias can cause true vertigo (spinning sensation), not just presyncope, and this represents a potentially life-threatening condition requiring urgent cardiac evaluation and rhythm monitoring.

Clinical Recognition

Cardiac dysrhythmias cause vertigo through transient cerebral hypoperfusion, and contrary to traditional teaching, this can manifest as true rotatory vertigo rather than just lightheadedness. In patients with cardiovascular causes of dizziness, vertigo was present in 63% and was the only dizziness type in 37% 1. A recent study of cardiogenic vertigo found that 52% of patients presented with recurrent isolated vertigo without any syncopal attacks, with symptoms persisting for a median of 122 days before diagnosis 2.

Key Clinical Features to Identify Cardiogenic Vertigo:

• Duration: Episodes last only seconds (93% of cases) or a few minutes (7%), not hours or days 2
• Age: Typically occurs in older adults (mean age 75 years, range 63-88) 2
• Temporal pattern: May occur before syncope (37%), after syncope (11%), or in isolation (52%) 2
• Associated symptoms (present in 70%): chest discomfort, palpitations, headache, arm twitching, or lightheadedness 2
• Exercise provocation: Consider ventricular tachycardia if dizziness occurs specifically during exertion 3

Specific Arrhythmias Causing Vertigo

Bradyarrhythmias are the most common culprit (89% of cases), including 2:

• Sick sinus syndrome with severe bradycardia or asystole 4
• High-grade AV block (Mobitz type II, complete heart block) 5
• Severe reflex bradycardia with asystolic pauses 4

Tachyarrhythmias can also cause vertigo 2, 3:

• Ventricular tachycardia (even in structurally normal hearts) 3
• Supraventricular tachycardia with rapid rates (>150 bpm) 6
• Atrial fibrillation with rapid ventricular response 7

Diagnostic Evaluation

Immediate Assessment:

• 12-lead ECG during symptoms if possible, or at minimum obtain rhythm strip before any intervention 8
• Look for: sinus bradycardia <50 bpm, pauses >3 seconds, second-degree or complete AV block, QRS >120ms suggesting bundle branch block 5
• Check for orthostatic vital signs (systolic BP drop ≥20 mmHg or diastolic ≥10 mmHg) 7

Extended Monitoring Strategy:

• 24-hour Holter monitoring if episodes occur daily 8
• Event recorder or wearable loop recorder for weekly episodes 8
• Implantable loop recorder for rare symptoms (<2 episodes/month) with severe symptoms or hemodynamic instability 8, 9
• The diagnostic yield of prolonged monitoring in patients with syncope/presyncope averages 43% 9

Additional Testing:

• Echocardiography to exclude structural heart disease 8
• Exercise testing if symptoms are clearly triggered by exertion 8, 3
• Electrophysiologic study for patients with bundle branch block and unexplained syncope, or when invasive diagnosis/ablation is planned 10

Treatment Approach

For Bradyarrhythmias:

Acute management 6:

• Atropine 0.5 mg IV, titrate up to 3 mg total for symptomatic bradycardia <40 bpm
• Prepare for temporary cardiac pacing if: pauses >3 seconds, Mobitz type II block, type II block with anterior MI, or previous asystole

Definitive treatment - Permanent pacing is indicated for 10, 5:

• Documented symptomatic sinus arrest or severe bradycardia causing vertigo/syncope
• Second-degree Mobitz II, advanced, or complete AV block with symptoms
• Bundle branch block with positive electrophysiology study
• Asymptomatic pauses in patients with unexplained syncope and sinus node disease

For Tachyarrhythmias:

Supraventricular tachycardia 6:

• If hemodynamically stable: vagal maneuvers first, then adenosine 3 mg IV rapid bolus (can repeat with 6 mg, then 12 mg)
• If unstable (systolic BP ≤90 mmHg, heart failure, chest pain, rate ≥150 bpm): synchronized cardioversion 100J → 200J → 360J
• Catheter ablation is first-choice definitive treatment for AVNRT, AVRT, or atrial flutter causing syncope 10

Ventricular tachycardia 6:

• If pulseless: immediate defibrillation per VF protocol
• If stable with pulse: lidocaine 1-3 mg/kg IV (100 mg bolus), then infusion 2-4 mg/min
• Catheter ablation indicated for VT with symptom-ECG correlation in structurally normal hearts 10
• ICD implantation indicated for documented VT with structural heart disease or depressed cardiac function 10

Critical Pitfalls to Avoid

• Do not dismiss true vertigo as purely vestibular in older adults with cardiac risk factors—37% of cardiovascular dizziness presents as isolated vertigo 1
• Do not use verapamil if patient takes beta-blockers (risk of profound bradycardia) or has Wolff-Parkinson-White syndrome (may precipitate VF) 6
• Do not initiate class I or III antiarrhythmics without documented arrhythmia due to proarrhythmia risk 8
• Do not attribute recurrent brief vertigo to benign causes without cardiac monitoring—patients may suffer symptoms for months (median 122 days) before diagnosis 2
• Adenosine must be given in monitored setting as it can cause transient complete heart block; avoid in asthmatics 6

The presence of spontaneous downbeat nystagmus during vertigo attacks does not exclude cardiac etiology—this was documented in one patient with bradyarrhythmia-induced vertigo 2. When clinical suspicion exists, consultation with cardiology and referral to a specialized center is warranted to ensure timely diagnosis and prevent sudden cardiac death 3.